Search Results - Bialobok, Paul

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion

    Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion by Bialobok, Paul, Cregan, Edward F., Sydserff, Simon G., Eisman, Mark S., Miller, Jerry A., Cross, Alan J., Simmons, Roy, Gendron, Patricia, McCarthy, Dennis J., Palmer, Gene C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The Low-Affinity, Use-Dependent NMDA Receptor Antagonist AR-R 15896AR: An Update of Progress in Stroke

    The Low-Affinity, Use-Dependent NMDA Receptor Antagonist AR-R 15896AR: An Update of Progress in Stroke by PALMER, GENE C., CREGAN, EDWARD F., BIALOBOK, PAUL, SYDSERFF, SIMON G., HUDZIK, THOMAS J., McCARTHY, DENNIS J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Laminin-like and laminin-binding protein-like immunoreactive astrocytes in rat hippocampus after transient ischemia. Antibody to laminin-binding protein is a sensitive marker of neural injury and degeneration

    Laminin-like and laminin-binding protein-like immunoreactive astrocytes in rat hippocampus after transient ischemia. Antibody to laminin-binding protein is a sensitive marker of ne... by Jucker, M, Bialobok, P, Kleinman, H K, Walker, L C, Hagg, T, Ingram, D K

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Laminin-like and Laminin-binding Protein-like Immunoreactive Astrocytes in Rat Hippocampus after Transient Ischemia

    Laminin-like and Laminin-binding Protein-like Immunoreactive Astrocytes in Rat Hippocampus after Transient Ischemia by JUCKER, MATHIAS, BIALOBOK, PAUL, KLEINMAN, HYNDA K., WALKER, LARY C., HAGG, THEO, INGRAM, DONALD K.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Development of a pharmacological target profile for muscarinic agonists

    Development of a pharmacological target profile for muscarinic agonists by Widzowski, Daniel V., Bialobok, Paul, Kucera, Kris E., Mihut, Roberta, Sitar, Shawn, Knowles, Marilyn, Stagnitto, Mary, Howell, Andrew, McCreedy, Sally, Machulskis, Anthony, Zongrone, John, Gordon, Jack, Marler, Matthew, Wu, Edwin S.C., Mullen, George, Triggle, David J., Blosser, James

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine by Falsey, Ann R, Sobieszczyk, Magdalena E, Hirsch, Ian, Sproule, Stephanie, Robb, Merlin L, Corey, Lawrence, Neuzil, Kathleen M, Hahn, William, Hunt, Julie, Mulligan, Mark J, McEvoy, Charlene, DeJesus, Edwin, Hassman, Michael, Little, Susan J, Pahud, Barbara A, Durbin, Anna, Pickrell, Paul, Daar, Eric S, Bush, Larry, Solis, Joel, Quito Osuna Carr, Oyedele, Temitope, Buchbinder, Susan, Cowden, Jessica, Vargas, Sergio L, Benavides, Alfredo Guerreros, Call, Robert, Keefer, Michael C, Kirkpatrick, Beth D, Pullman, John, Tong, Tina, Isaacs, Margaret Brewinski, Benkeser, David, Janes, Holly E, Nason, Martha C, Green, Justin A, Kelly, Elizabeth J, Maaske, Jill, Mueller, Nancy, Shoemaker, Kathryn, Takas, Therese, Marshall, Richard P, Pangalos, Menelas N, Villafana, Tonya, Gonzalez-Lopez, Antonio

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: